1. Trang chủ
  2. » Giáo Dục - Đào Tạo

lua chon stent thuong hay stent phu thuoc

45 104 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 45
Dung lượng 3,63 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction 15 RCT 2012 A

Trang 1

Can thiệp cấp cứu động mạch vành: lựa chọn stent trần hay stent phủ thuốc

-

TS Nguyễn Cửu Lợi Trung tâm Tim mạch – Bệnh viện Trung Ương Huế

Trang 3

Maarten A Vink, Maurits T Dirksen, Maarten J Suttorp, Jan G.P Tijssen, Jeroen van Etten, Mark S Patterson, Ton Slagboom, Ferdinand Kiemeneij, Gerrit J Laarman

• Randomly assigned 619 patients presenting with STEMI to a paclitaxel-eluting stent (PES) or the similar BMS

• The primary end point was the composite of cardiac death,

recurrent myocardial infarction, or TLR

• Follow-up at 5 years

Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation [ PASSION ]

Trang 6

Conclusions

In the present analysis of PES compared with BMS in primary

percutaneous coronary intervention for STEMI:

- No significant difference in major adverse cardiac events

was observed

- In addition, no difference in the incidence of definite or

probable ST was seen, although very late ST was almost

exclusively seen after the use of PES

J Am Coll Cardiol Intv 2011;4:24–9

Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation [PASSION]

Trang 9

Ev

Trang 12

- 3980 (63.2%) DES (99% PES & SES)

- 2318 (36.8%) BMS

Trang 15

Bindu Kalesan, Thomas Pilgrim, Katja Heinimann, Lorenz Räber, Giulio G Stefanini, Marco Valgimigli, Bruno R da Costa, François Mach, Thomas F Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (15 RCT)

2012 Apr;33(8):977-87

Trang 16

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)

Overall

Year 1

Subsequent year

Trang 17

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)

Overall

Year 1

Subsequent year

Trang 18

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction (cont’)

Trang 19

Bindu Kalesan, Thomas Pilgrim, Katja Heinimann, Lorenz Räber, Giulio G Stefanini, Marco Valgimigli, Bruno R da Costa, François Mach, Thomas F Lüscher, Bernhard Meier, Stephan Windecker, Peter Jüni

CONCLUSION

An early benefit of early generation DES in primary

PCI for STEMI with a reduction in TVR and a trend

towards less definite ST is offset in subsequent years

by an increased risk of very late ST

Comparison of drug-eluting stents with bare metal stents in patients with ST-segment

elevation myocardial infarction (cont’)

Trang 20

Paclitaxel-Eluting Stents versus Bare-Metal Stents

in Acute Myocardial Infarction

Gregg W Stone, M.D., Alexandra J Lansky, M.D., Stuart J Pocock, Ph.D.,

Bernard J Gersh, M.B., Ch.B., D.Phil., George Dangas, M.D., Ph.D., S Chiu Wong, M.D., Bernhard Witzenbichler, M.D., Giulio Guagliumi, M.D., Jan Z Peruga, M.D., Bruce R Brodie, M.D., Dariusz Dudek, M.D., Martin Möckel, M.D., Andrzej Ochala, M.D., Alison Kellock, B.S., Helen Parise, Sc.D., and

Roxana Mehran, M.D for the HORIZONS-AMI Trial Investigators

Trang 21

Stone GW et al N Engl J Med 2009;360:1946-1959

Kaplan–Meier Time-to-Event Curves for Primary End Points and Three Components of the Primary Composite Safety End Point

HR, 0.59; 95% CI, 0.43 to 0.83; P=0.002 HR, 1.02; 95% CI, 0.76 to 1.36; P=0.01

HR, 0.97; 95% CI, 0.70 to 1.32; P=0.83 HR, 0.93; 95% CI, 0.59 to 1.47; P=0.77

Trang 28

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients

With ST-Segment Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

Rev Esp Cardiol 2009;62(04):354-64

Raisuke Iijimaa, Robert A Byrnea, Alban Dibraa, Gjin Ndrepepaa, Christian

Spauldingb, Gerrit J Laarmanc, Maurizio Menichellid, Marco Valgimiglie, Emilio

Di Lorenzof, Christoph Kaiserg, Ilkka Tieralah, Julinda Mehillia, Maarten J

Suttorpi, Roberto Violinid, Albert Schömiga, Adnan Kastratia

Trang 29

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment

Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

Rev Esp Cardiol 2009;62(04):354-64

Trang 30

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment

Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

Rev Esp Cardiol 2009;62(04):354-64

Trang 31

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment

Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

Rev Esp Cardiol 2009;62(04):354-64

Trang 32

Drug-Eluting Stents Versus Bare-Metal Stents in Diabetic Patients With ST-Segment

Elevation Acute Myocardial Infarction: A Pooled Analysis of Individual Patient Data From Seven Randomized Trials

Rev Esp Cardiol 2009;62(04):354-64

CONCLUSIONS

In conclusion, use of DES in diabetic patients

undergoing primary stenting for STEMI reduces the

need for repeat intervention without increasing the

rate of thrombosis-related events as compared to

BMS

Trang 45

HỘI NGHỊ TIM MẠCH CAN THIỆP

26-27/03/2016

TP Huế

Ngày đăng: 17/06/2016, 22:18

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

w